Bizarre Patents
A method for inducing cats to exercise consists of directing a beam of invisible light produced by a hand-held laser apparatus onto the floor or wall.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7361362 | Emulsion composition The present invention is an emulsified composition comprising (a) 0.01-5 wt % polysiloxane-polyoxyalkylene copolymer, (b) 0.05-1 wt % nonionic surfactant, (c) 10-30 wt % humectant, and (d) 1-50 wt % urea. The present invention provides an emulsified formulation of a... | 04/22/2008 |
| 7316821 | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer A stabilized solid controlled release dosage form having a coating derived from an aqueous dispersion of ethylcellulose is obtained by overcoating a substrate including a therapeutically active with an aqueous dispersion of ethylcellulose and then curing the coated ... | 01/08/2008 |
| 7307043 | Aqueous neonicotinoid compositions for seed treatment An aqueous composition suitable for applying insecticides or acaricides to plant propagation materials comprising water, an insecticidally or acaricidally effective amount of at least one nitroimino- or nitroguanidino-compound in free form or in agrochemically usefu... | 12/11/2007 |
| 7244418 | Antimicrobial artificial nail composition and methods for preparing and using same A composition for forming an antimicrobial artificial nail, a method for preparing the same, and a method for treating a microbial infection of a nail plate are provided. The composition comprises a binder component; a filler component which polymerizes to form an a... | 07/17/2007 |
| 7229630 | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof The present invention provides compositions and stable liquid formulations comprising alpha adrenergic receptor antagonists and use thereof for increasing blood flow. In one embodiment, the stable liquid formulations of this invention are useful for reversing the ef... | 06/12/2007 |
| 7226615 | Expandable foam-like biomaterials and methods Liquid, injectable, aqueous solutions are transformed in situ to an expandable foam-like, space filling, and adherent biomaterial. Preferably, the foam-like biomaterial is the reaction product of a two-part liquid system to achieve the in situ formation thereof. The... | 06/05/2007 |
| 7202281 | Methods and compositions for reducing or eliminating post-surgical adhesion formation The present invention relates to a method for reducing adhesions associated with post-operative surgery. The present method comprises administering or affixing a polymeric composition preferably comprising chain extended, coupled or crosslinked polyester/poly(oxyalk... | 04/10/2007 |
| 7201923 | Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles A liquid encapsulant component which contains an active, sensitive encapsulant, such as a live microorganism or an enzyme dissolved or dispersed in a liquid plasticizer is admixed with a plasticizable matrix material. The matrix material is plasticizable by the liqu... | 04/10/2007 |
| 7192599 | Mattifying oil-in-water emulsion The present invention relates to cosmetic and pharmaceutical oil-in-water emulsions which have a mattifying effect when applied to the skin. The invention comprises a hydrophilic, non-organically modified magnesium aluminum silicate or a bentonite clay and a polyol ... | 03/20/2007 |
| 7192604 | Implantable biodegradable devices for musculoskeletal repair or regeneration An implantable biodegradable device is disclosed containing a fibrous matrix, the fibrous matrix being constructed from fibers A and fibers B, wherein fibers A biodegrade faster than fibers B, fibers A and fibers B are present in relative amounts and are organized s... | 03/20/2007 |
| 7189413 | Drug delivery of proteins from polymeric blends Degradable blend of polycaprolactone and crystallization modifier especially suitable for use in the controlled release of biologically active proteins ... | 03/13/2007 |
| 7189414 | Controlled release oral drug delivery system The invention relates to synchronous drug delivery composition comprising a polymeric matrix which comprises hydrogel blended with a hydrophobic polymer, so as to form an erodible matrix, a drug, and, optionally, an agent which enhances intestinal drug absorption an... | 03/13/2007 |
| 7172770 | Mesoporous compositions for use in drug delivery The present invention encompasses novel mesoporous compositions comprising vitamin E and alumina, and methods for their synthesis. The mesoporous compositions of the present invention have applications as drug-delivery vehicles. ... | 02/06/2007 |
| 7169411 | Composition for delivery of biological agents and methods for the preparation thereof A composition for facilitating delivery of biological agents, comprising a therapeutic or diagnostic agent and a supramolecular complex, the latter comprising (i) a block copolymer, having at least one nonionic, water soluble segment and at least one polyionic segme... | 01/30/2007 |
| 7163699 | Progestin co-micronized with a surfactant pharmaceutical composition comprising same methods for making same and uses thereof The invention concerns a progestin co-micronized with a surfactant and a pharmaceutical composition comprising said gestagenic. The invention also concerns methods for preparing same. ... | 01/16/2007 |
| 7160557 | Matrices formed of polymer and hydrophobic compounds for use in drug delivery A lipid or other hydrophobic or amphiphilic compound (collectively referred to herein as “hydrophobic compounds”) is integrated into a polymeric matrix for drug delivery to alter drug release kinetics. In embodiments where the drug is water soluble, the drug is ... | 01/09/2007 |
| 7153522 | Sorbefacients and preparations for percutaneous absorption containing the same Percutaneous sorbefacients comprising hexylene glycol and 1-menthol, more particularly, percutaneous sorbefacients for female hormones or derivatives thereof; and preparations for percutaneous absorption which comprise a styrene/isoprene/styrene block copolymer and/... | 12/26/2006 |
| 7153518 | Processed soft tissue for topical or internal application Disclosed herein are novel injectable, biocompatible compositions, preferably, comprising a combination of particulate, processed tissue and a carrier. Specifically disclosed are compositions comprising acellular, pulverized dermis combined with at least one glycosa... | 12/26/2006 |
| 7150881 | Adhesive mixture for transdermal delivery of highly plasticizing drugs Transdermal drug delivery patches and methods of their production are described. The patches can be made such that the accommodate highly plasticizing drugs such as selegiline and/or the use of protonated forms of various drugs. ... | 12/19/2006 |
| 7138106 | Compositions for use in embolizing blood vessels Disclosed are compositions suitable for use in embolizing blood vessels which compositions comprise a polymer, a biocompatible solvent and a contrast agent. The polymer is selected from the group consisting of polyacrylonitrile, polyurethane, polyvinylacetate, cellu... | 11/21/2006 |
| 7138133 | Orally administered liquid compositions The present invention is an orally administered liquid pharmaceutical composition that demonstrates excellent physical stability while delivering concentrated levels of the pharmaceutical active(s). Specifically, these compositions for extended periods do not allow ... | 11/21/2006 |
| 7128927 | Emulsions for in-situ delivery systems The invention is provides a composition for sustained delivery of a biologically active agent comprising a biologically active mixture and a controlled release formulation. The composition protects the biologically active agent from being destroyed by the controlled... | 10/31/2006 |
| 7125547 | Poly(diallylamine)-based bile acid sequestrants The present invention relates to a method for removing bile acids from a patient and certain polymers of use in the method. The method comprises the step of administering to the patient a therapeutically effective amount of a polymer composition which includes a a p... | 10/24/2006 |
| 7122205 | Bioerodable polymeric adhesives for tissue repair Methods for tissue repair are provided employing a matrix comprising a biocompatible, bioerodable polymer, said polymer comprising a thermoplastic lactide-containing terpolymer of monomer units derived from lactic acid, glycolic acid, and either caprolactone or vale... | 10/17/2006 |
| 7115281 | Processes for the preparation of oral dosage formulations of modafinil The invention relates to processes for preparing, and pharmaceutical compositions of, modafinil dosage forms for oral administration. The dosage forms include a mixture of coarse and fine particles of modafinil. The process for preparing modafinil oral dosage forms ... | 10/03/2006 |
| 7105153 | Thickener-rheology modifier system for personal care compositions A thickener-rheology modifier system for use in hair care and skin care compositions comprising: a) a hydrophobically modified, alkali-soluble copolymer thickener comprising an aqueous emulsion copolymer of: ... | 09/12/2006 |
| 7097849 | Injectable aqueous dispersions of propofol Irritation upon injection of a formulation containing propofol is reduced or substantially eliminated by administering a stable, sterile, and antimicrobial aqueous dispersion comprising a water-insoluble microdroplet matrix of mean diameter from about 50 nm to about... | 08/29/2006 |
| 7097853 | Matrix for transdermal drug delivery A transdermal drug delivery device involving a macromonomer-containing acrylate or methacrylate copolymer, a softener, and a drug. Also a pressure sensitive skin adhesive involving a macromonomer containing acrylate or methacrylate copolymer and a softener. ... | 08/29/2006 |
| 7097855 | Transdermal thermal polymerization An invention for polymerizing or crosslinking a prepolymer using a water soluble, thermal polymerization initiator is disclosed. The prepolymer mixed with the initiator is injected or placed into an animal's body, and heat is applied over the site of the injection t... | 08/29/2006 |
| 7094395 | Pigment dispersion and related method of manufacture A method for producing a colored cosmetic composition having inorganic pigments resistant to agglomeration in an oil-in-water emulsion. The method includes the following: preparing an oil dispersion by adding inorganic pigments directly to an oil; preparing an aqueo... | 08/22/2006 |
| 7090867 | Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum The present invention provides a controlled release device for sustained or pulsatile delivery of pharmaceutically active substances for a predetermined period of time. This invention further provides such device in which sustained or pulsatile delivery is obtained ... | 08/15/2006 |
| 7087619 | Method for the treatment of urinary incontinence Urinary incontinence is alleviated in a mammal by administering to the mammal a urinary incontinence alleviating amount of dextromethorphan, dextrorphan, their mixtures and/or pharmaceutically acceptable salts, alone or in combination with a pharmacologically active... | 08/08/2006 |
| 7078046 | Electrostatically-sprayable topical compositions having insulating external phase and conductive internal phase Disclosed are electrostatically-sprayable topical compositions, more particularly topical emulsion compositions, and methods of treating the skin by electrostatic application of such compositions. In one aspect the composition comprises an insulating external phase ... | 07/18/2006 |
| 7070808 | Adhesive mixture for transdermal delivery of highly plasticizing drugs Transdermal drug delivery patches and methods of their production are described. The patches can be made such that the accommodate highly plasticizing drugs such as selegiline and/or the use of protonated forms of various drugs. ... | 07/04/2006 |
| 7067151 | Controlled absorption diltiazem pharmaceutical formulation A controlled absorption diltiazem pellet formulation for oral administration comprises a core having diltiazem or a pharmaceutically acceptable salt thereof as the active ingredient. The core is surrounded by a coating which has only a single layer which is comprise... | 06/27/2006 |
| 7063858 | Sweet with a rough texture intended for the treatment of halitosis The invention relates to a sweet of boiled sugar type exhibiting a rough texture intended for the treatment of halitosis as well as process for making the same and a method for treating halitosis using the same. ... | 06/20/2006 |
| 7063834 | Cosmetic compositions based on multiblock ionizable polycondensates, and uses thereof The invention relates to novel cosmetic or dermatological compositions, characterized in that they comprise, in a cosmetically acceptable support, at least one solution or one emulsion of at least one multiblock polycondensate whose chain consists of the repetition ... | 06/20/2006 |
| 7060296 | Hydrolysable hydrogels for controlled release The present invention relates to a biodegradable hydrogel comprising bonds which are hydrolyzable under physiological conditions. More particularly, the hydrogel consists of two interpenetrating polymer networks interconnected to one another through hydrolyzable spa... | 06/13/2006 |
| 7060734 | Pharmaceutical coating composition and method of use A composition is disclosed comprising a polymer and a surfactant in a solvent exhibiting a common solubility for the polymer and the surfactant. The composition provides a dosage form for administering a drug over time. ... | 06/13/2006 |
| 7056951 | Stable solid dosage forms of amino acids and processes for producing same Pharmaceutical formulations, and processes for making same, comprising an amino acid which is liable to formation of an undesirable lactam, and a stabilizer comprising a volatile alcohol; a non-volatile alcohol; a water immiscible liquid or solid; a liquid with a re... | 06/06/2006 |
